General Statement of Disclosure:
CONSULTING FEES/HONORARIA: Novartis Corporation(MODEST), Tempus Labs(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Janssen Pharmaceuticals, Inc(SIGNIFICANT) OTHER FINANCIAL BENEFIT: EasyG(NONE), physIQ(SIGNIFICANT)
The ACC will perform system updates on Oct. 15 from 8-11 p.m. ET. During this time, online purchases and payment processing will be unavailable. Thank you for your understanding.
CONSULTING FEES/HONORARIA: Novartis Corporation(MODEST), Tempus Labs(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Janssen Pharmaceuticals, Inc(SIGNIFICANT) OTHER FINANCIAL BENEFIT: EasyG(NONE), physIQ(SIGNIFICANT)